Scientists at Berkeley Lab’s Molecular Foundry have joined forces with a research team at Stanford to aim a gene-targeting, antiviral agent called PAC-MAN against COVID-19. The cellular delivery system, developed at Berkeley Lab, could be missing link in battle against SARS-CoV-2. https://newscenter.lbl.gov/2020/06/04/gene-targeting-covid-19/